Ovid Therapeutics Net Tangible Assets

Ovid Therapeutics (OVID) currently reports a net tangible assets of $210M as of June 2026. That compares with $56M in the prior-year period — up 276.2% year over year. Use the charts on this page to explore Ovid Therapeutics's net tangible assets history and peer comparisons.

Ovid Therapeutics's net tangible assets increased from $56M to $210M — a 276.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ovid Therapeutics reported $210M in net tangible assets as of June 2026. That compares with $56M in the prior-year period — up 276.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $210M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ovid Therapeutics, and consider following OVID for alerts when major investors trade the stock.

Ovid Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $210M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OVID with unrelated industries.